Reviewer Guidelines

Purpose of Review

Pharminsight seeks to publish high-quality, experience-driven content that advances thinking within the pharmaceutical, biotechnology, healthcare, manufacturing, regulatory, investment, and innovation ecosystems.

Reviewers play a critical role in maintaining the quality, credibility, and relevance of published content.

Unlike traditional scientific journals, reviewers are expected to assess submissions primarily for practical value, accuracy, originality of thought, and industry relevance.

Reviewer Responsibilities

Reviewers should evaluate whether the submission:

• Addresses a relevant industry challenge, opportunity, or emerging trend.
• Demonstrates original thinking or practical insights.
• Is factually accurate and balanced.
• Provides actionable recommendations or useful perspectives.
• Is written clearly and professionally.
• Maintains ethical and professional standards.

Evaluation Criteria

1. Relevance: does the topic address a significant issue for industry, academia, startups, regulators, investors, or healthcare stakeholders?
2. Originality: does the article contribute new insights, practical experiences, frameworks, or perspectives?
3. Technical Accuracy: are technical claims supported by evidence, established practice, or credible references?
4. Practical Impact: will readers gain meaningful knowledge that can influence decision-making, strategy, policy, or implementation?
5. Clarity: is the content organized logically and written in a clear, concise manner?
6. Balance: are opposing viewpoints acknowledged where appropriate?

Reviewer Recommendations

Reviewers may recommend Accept, Minor Revision, Major Revision, or Reject. Reviewers should provide constructive comments that help authors strengthen their submissions. The recommendation goes to the editor, who makes the final decision.

Confidentiality

All submissions must be treated as confidential. Reviewers shall not:

• Share submitted content.
• Use unpublished information for personal or professional benefit.
• Disclose review discussions outside the review process.

Conflict of Interest

Reviewers must decline assignments when they have:

• Direct financial interests.
• Active collaborations with the author.
• Competitive conflicts.
• Any circumstance that could compromise objectivity.

Professional Conduct

Reviews should be respectful, constructive, objective, and evidence-based. Personal criticism or inappropriate language will not be tolerated.

Review Timeline

Reviewers are requested to submit reviews within 14 days of assignment unless otherwise agreed with the Editorial Team.